It was an honor to contribute to the #AACRBlog with my colleague Robert Kruger to discuss our recent visits to China. Looking forward to visiting again next month!

The @aacrjournals.bsky.social editors are working to ensure that AACR publications reflect the best science from around the world. Learn about their efforts to strengthen connections with the research community in China on the #AACRBlog: buff.ly/T5fkQef

From mutant mice to meaningful signals: Read about Nobel laureate Fred Ramsdell’s #AACRIO26 keynote on regulatory T cells and immune tolerance on the #AACRBlog: buff.ly/N6PBOS4 #AACRBlog

Cancer vaccines are here, and research is identifying how to push T cells even further so they thrive in the tumor microenvironment. Learn more about the opening‑night #AACRIO26 keynote addresses from #AACRFellows Elizabeth Jaffee and Philip Greenberg on the #AACRBlog: buff.ly/uKglwKq

Younger adults are being diagnosed with colorectal cancer more and more frequently. But how can the disease be caught early? Learn more about different ways to screen on the #AACRBlog during #CancerPreventionMonth: buff.ly/icsInUf

Twenty early-career researchers from around the world were selected for this year’s AACR Global Scholar-in-Training Awards (GSITAs) and the newly launched Amgen GSITAs. Learn more about the recipients and how this program could help further their careers on the #AACRBlog: buff.ly/lIyzm9e

The newest post in the From the Bench series looks at smarter cancer vaccines: engineering where the vaccine goes, how loudly it signals, and which targets T cells see first. Read more on the #AACRBlog: buff.ly/4wXtWea

As Elizabeth M. Jaffee and Antoni Ribas take over as the new editors-in-chief of Cancer Immunology Research, they share how they got started in immunotherapy research, their vision for the AACR journal, and what excites them about #AACRIO26 on the #AACRBlog: buff.ly/2QY3kFY

For January, the editors of AACR’s 10 peer-reviewed journals highlighted studies about better understanding the naked mole rat’s cancer resistance, the importance of using tissue and liquid biopsy in concordance, and more Read on the #AACRBlog: buff.ly/vi2eP6h

What are fusion proteins? And what do they have to do with cancer? Learn more about these strange chimeric molecules and the improperly combined genes that create them on the #AACRBlog: buff.ly/5RLESr7

AACR member leader Marcia Cruz‑Correa forecasts how disparities in cancer will be addressed in 2026, including accessible screening, community‑based precision care, and treating obesity to reduce cancer risk. buff.ly/YFPE2AR #AACRBlog

At the AACR Special Conference on The Rise in Early-Onset Cancers, scientists pointed to several possible causes—like microplastics—and how such factors might be mitigated. Learn more on the #AACRBlog: buff.ly/E4oJWJR #AACRearlyonset25

“The Rise in Early-Onset Cancers—Knowledge Gaps and Research Opportunities,” an AACR Special Conference, brought together researchers to share findings and ideas on possible explanations for the increase in these diagnoses. Learn more on the #AACRBlog: www.aacr.org/blog/2026/01... #AACRearlyonset25

The #AACRBlog Experts Forecast 2026 includes expectations from William Hait, Keith Flaherty, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa on cancer prevention and detection, precision medicine, immunotherapy, AI, and cancer disparities: buff.ly/s12OrAt

The studies highlighted by AACR’s journal editors in December include a potential strategy for preventing colorectal cancer involving the gut microbiome, a potent molecular glue for treating pancreatic cancer, and more. Learn more on the #AACRBlog: buff.ly/2uDKHsW

Check out a year-end review on the #AACRBlog covering new FDA-approved cancer treatments; research advances in cancer interception, immunotherapies, ctDNA, and AI; and more discoveries from 2025: buff.ly/3WNmb8Q

Data presented at #SABCS25 showed that certain patients can skip sentinel node surgery or pre‑op MRI. Visit the #AACRBlog to learn more: buff.ly/AgbGFLY
@sabcs.bsky.social

New work presented at the San Antonio Breast Cancer Symposium provides some clarity for women with BRCA1 and/or BRCA2 mutations: Menopausal hormone therapy does not increase their risk of breast cancer. Learn more on the #AACRblog: buff.ly/yx1QleK #SABCS25 @sabcs.bsky.social

We’ve tracked tucatinib’s journey from a later-line option to a potential first‑line maintenance therapy based on the data presented at #SABCS25. Visit the #AACRBlog to learn more: buff.ly/z7SKOed

Opportunities for improving dose optimization were discussed at the 2025 AACR-Industry Roundtable. Learn more on the #AACRBlog: buff.ly/QQSv1mg

The inaugural AACR #PediatricCancerProgressReport details how research advances have led to over 30 new treatments for pediatric cancers in the last decade, while also highlighting the gaps in care that still exist. Check out highlights from the report on the #AACRBlog: buff.ly/KnmJUIo

Among the studies highlighted by the editors of AACR’s journals in November were sucralose’s effect on immunotherapy and a gene signature predictive of CAR T-cell therapy response. Learn more on the #AACRBlog: buff.ly/82t95Sc
@aacrjournals.bsky.social

Shawn Lee, MD, PhD, received a grant from the AACR and The St. Baldrick’s Foundation to support his work on tailoring therapies for patients with pediatric ALL in Southeast Asia, where he hopes to improve survival and outcomes. Learn more on the #AACRBlog: buff.ly/b2sr9Vq

We're off and running! Follow our first-ever live coverage #AACRBlog as one of our writers, Steve Schneible, runs the Philly half marathon with the AACR #Runners4Research team during Philadelphia Marathon Weekend at buff.ly/sQVzO0s.

Live from @Philly_Marathon Weekend! The #AACRBlog follows Steve Schneible, one of our writers, as he runs the half marathon with AACR #Runners4Research. Follow the race in real time: buff.ly/sQVzO0s

Tomorrow, we're bringing you the first-ever live #AACRBlog from Steve Schneible, one of our writers, as he tackles the half marathon as part of the AACR #Runners4Research team during Philly Marathon Weekend. Follow along: buff.ly/sQVzO0s

With the AACR Special Conference on Cancer Evolution coming up on December 4-6, the #AACRBlog spoke with conference cochair @marasherman.bsky.social and AACR Cancer Evolution Working Group chair Laura M. Heiser about what to expect: buff.ly/qBq6LgO #AACRevol25

Promising early-phase clinical trial results for several first-in-class therapeutics with innovative mechanisms of action and cutting-edge technologies were recently presented at #Targets25. Learn more on the #AACRBlog: buff.ly/hNZxH9V

The AACR Grantee Summit brought together scientists whose work is transforming cancer science and medicine. Learn more about TP53 status as a therapy guide, strategies for tackling metastasis, and innovative approaches for rare cancers on the #AACRBlog: buff.ly/qTsyJ2H

Learn more about risk factors for multiple myeloma, how it is diagnosed, and other potential treatment options on the #AACRBlog: buff.ly/34oe1Kg